Posted on 2/21/18
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BRIDGEWATER, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today . . .
Posted on 2/21/18
Advaxis Announces Proposed Public Offering of Common Stock
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of cancer immunotherapies, today announced that it intends to offer . . .
Posted on 2/21/18
Johnson & Johnson SEC Filing - Annual Report (10-K)
Johnson & Johnson (JNJ) (NYSE: JNJ) today announced sales of $20.2 billion for the fourth quarter of 2017, an increase of 11.5% as compared to the . . .
Posted on 2/21/18
6 Reasons Buffett Bought Into Teva Pharmaceutical, as Told by a Teva Shareholder
The past couple of years have been rough on Teva Pharmaceutical Industries (NYSE:TEVA)and its shareholders. The largest maker of generic drugs and developer of a handful . . .
Posted on 2/20/18
Theravance Biopharma: Johnson & Johnson Deal Looks Solid
Shares of Theravance Biopharma (NASDAQ:TBPH) have finished slightly in the red since my initial article from mid-November in which I stated the stock was "undervalued with . . .
Posted on 2/20/18
Teva: Berkshire Is Barking Up The Wrong Tree
Warren Buffett of Berkshire Hathaway. Source: medium.comTeva (TEVA) reported more disappointing results for Q4. Revenue and EBITDA fell Y/Y by 16% and 29%, respectively. Somehow Berkshire . . .
Posted on 2/20/18
How Celgene Hopes to Cash In on CAR-T
Chimeric antigen T-cell therapy (CAR-T) is an important new approach to battling blood cancer, and while it's too soon to say what company will develop an . . .
Posted on 2/20/18
Celgene's Otezla-Colitis Story; Implications For Other Biotechs
IntroductionCelgene (CELG) is back to 2014 levels, closing Friday at $96.14. It first reached this price in August 2014. Yet I just want to sit with . . .
Posted on 2/20/18
Is Celgene A Growth Or A Value Stock?
Celgene's Long-Lasting UnderperformanceIf an average Joe invested $100 in Celgene's (NASDAQ:CELG) stock in 2015, he would have lost $17 now. At the same time, if he . . .
Posted on 2/20/18
5 Things You Need to Know About Celgene's Future
Celgene (NASDAQ:CELG) had a horrible, rotten, no-good, lousy year in 2017. At least that's how some people look at it.In reality, the big biotech saw net . . .
Posted on 2/20/18
Why in the World Does Warren Buffett Like Teva Pharmaceutical?
Say it ain't so, Warren.Warren Buffett's Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) filed an update of its investment holdings to the U.S. Securities and Exchange Commission (SEC) on . . .
Posted on 2/19/18
PANTHERx Specialty Pharmacy Awarded Fourth Accreditation from VIPPS
PANTHERx Specialty Pharmacy®, THE Rare Disease Specialty Pharmacy®, announced today that it has received the Verified Internet Pharmacy Practice Sites (VIPPS) accreditation from the National Association . . .
Posted on 2/16/18
BD Completes Asset Divestitures to Merit Medical
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has completed the previously announced divestitures of its soft . . .
Posted on 2/16/18
PMD Healthcare Announces Two New Patient Advisory Boards
PMD Healthcare, a medical device, digital health and chronic care management services company, has announced it is forming two new patient advisory boards: one for Cystic . . .
Posted on 2/16/18
Amicus Therapeutics Prices Underwritten Offering of Common Stock
CRANBURY, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced the pricing of an underwritten offering of 19,354,839 shares of its common stock . . .
Posted on 2/15/18
Antares Pharma Announces FDA Approval of Partner’s Product Utilizing Our QuickShot Auto Injector
EWING, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced the successful regulatory outcome of the Makena® subcutaneous auto injector collaboration with . . .
Posted on 2/15/18
Why I Recently Bought Johnson & Johnson
In mid-November 2017, I wrote an article titled, “Johnson & Johnson: Does This Dividend Giant Still Offer Value?” This piece discussed why I viewed Johnson & . . .
Posted on 2/15/18
Behind The Idea: Teva's Tribulations (Podcast)
Teva Pharmaceutical's (TEVA) main business is generic drugs, but the story has been quite original over the last few years. The company has had 3 CEOs . . .
Posted on 2/15/18
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
Arena Pharmaceuticals (NASDAQ:ARNA) plans to roll out phase 2 results for etrasimod this quarter, and Celgene (NASDAQ:CELG) investors ought to be paying attention. That's because etrasimod . . .
Posted on 2/15/18
Celgene Announces Additional $5 Billion Share Repurchase Authorization
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced the Company's Board of Directors authorized the repurchase of an additional $5 billion of the Company's common stock. . . .
Posted on 2/14/18
Amicus Therapeutics Announces Public Offering of Common Stock
CRANBURY, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced it has commenced a $250 million underwritten public offering of its common stock. . . .
Posted on 2/14/18
Better Buy: Eli Lilly and Company vs. Johnson & Johnson
If you had bought $10,000 of Eli Lilly and Company (NYSE:LLY) stock 10 years ago and held it, your initial investment would now be worth roughly . . .
Posted on 2/14/18
This Potentially Game-Changing News Sent AmerisourceBergen Corp. as Much as 14% Higher
What happenedShares of AmeisourceBergen (NYSE:ABC), a distributor of brand-name and generic drugs and a pharmacy supply chain management company, soared by as much as 14% Tuesday . . .
Posted on 2/13/18
Oncobiologics Receives Positive Nasdaq Listing Determination
CRANBURY, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (NASDAQ:ONSIW) (NASDAQ:ONSIZ) announced today that on February 13, 2018, the Company received formal notice that . . .
Posted on 2/13/18
Konica Minolta Healthcare Highlights MSK Ultrasound Education and Solutions at AAP’s Physiatry ‘18 Annual Meeting
WAYNE, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. continues to support ultrasound education for physiatrists in physical medicine and rehabilitation with . . .

